In a great relief to parents who have waited for more than a year-and-a-half to vaccinate their youngest, Food and Drug Administration (FDA) advisers unanimously voted on Wednesday to recommend authorizing both Moderna and Pfizer-BioNTech’s Covid-19 vaccines for young children.
The Vaccine and Related Biological Products Advisory Committee held a vote for each vaccine during its Wednesday meeting. Both recommendations were unanimous. While the committee’s recommendations aren’t the final signoff needed to greenlight the shots, the votes will now set off a fast-moving process expected to be completed by next Tuesday. The decision will now go to the FDA, which is expected to grant emergency use authorization to the vaccines in the coming days. On Friday and Saturday, an advisory panel to the Centers for Disease Control and Prevention (CDC) is expected to vote on whether to endorse the shots. The final step is a signoff from CDC Director Dr. Rochelle Walensky.
Clinical trial data presented by both Moderna and Pfizer representatives at Wednesday’s meeting showed the vaccines were safe and effective in the youngest kids. The vote clears one of the final hurdles to getting the youngest Americans vaccinated. Moderna’s vaccine is for children ages 6 months to 5 years, while Pfizer’s is for children ages 6 months to 4 years.
BREAKING: FDA's external advisory committee votes unanimously to authorize Moderna's COVID-19 vaccination for use in children 6 months through 5 years of age
Also breaking: this parent is shedding tears of joy
— Dr. Jorge A. Caballero stands with 🇺🇦 (@DataDrivenMD) June 15, 2022